U.S. Digestive Health CEO Jerry Tillinger recently joined Becker’s to discuss what he thinks will disrupt the gastroenterology industry next.
Editor’s note: This response was edited lightly for length and clarity.
Question: What will disrupt the GI industry next?
Jerry Tillinger: It’s a rapidly moving industry — there’s technology changes, there’s medicine changes and there’s a ton of things that are hitting us all the time. But the one that I think is actually going to drive the most change for us is the rapid growth and the demand for outpatient procedures as we’ve moved the bar for colonoscopy screening from 50 to 45.